Their infiltration within the tumor microenvironment has been inversely correlated with tumor progression, and low CD8+ T cell infiltration is associated with poorer clinical outcomes in COAD patients, emphasizing their importance in mediating anti-tumor immunity (Galon et al., 2006; Hartman et al., 2020; Li et al., 2020). This evidence concerns the gene CD8A and neoplasm.